Smartphone-based dual radiometric fluorescence and white-light imager for quantification of protoporphyrin IX in skin
Open Access
- 1 August 2023
- journal article
- research article
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (08) , 086003-21
Abstract
The detection and quantification of protoporphyrin IX (PpIX) is an important diagnostic tool in various medical fields, including dermatology and oncology.1 – 3 Within dermatology, PpIX-based skin photodynamic therapy (PDT) is increasingly used for the clinical treatment of actinic keratosis (AK) lesions, replacing traditional cryosurgery, chemical peel, and curettage treatments.4,5 Despite the widespread clinical use of skin PDT, the primary treatment outcome of AK lesion clearance rates varies widely, which is primarily caused by heterogeneous accumulation of the photosensitizer PpIX between patients and between lesions.6,7 Furthermore, the presence and accumulation of PpIX in skin is also related to conditions like porphyria8,9 and can be used for the preoperative mapping of non-melanoma skin cancers.10,11 Therefore, the ability to visualize and quantify skin PpIX in clinical settings can be used to help guide critical decisions at the point-of-care, including mitigative actions to improve patient outcomes. Imaging and spectroscopy techniques have shown potential for PpIX quantification, with fluorescence (FL) imaging techniques demonstrating great promise for non-invasive measurement of PpIX in the skin.6,12 Additionally, smartphone-based imaging (SBI) devices have emerged as a promising approach for PpIX quantification, offering cost-effective solutions that could be integrated into the clinical workflow.13 – 15Keywords
This publication has 37 references indexed in Scilit:
- Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosisJournal of Biomedical Optics, 2014
- Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy nduced clinical erythemaJournal of Biomedical Optics, 2014
- Correlation between Protoporphyrin IX Fluorescence Intensity, Photobleaching, Pain and Clinical Outcome of Actinic Keratosis Treated by Photodynamic TherapyDermatology, 2013
- European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen’s disease, basal cell carcinomaJournal of the European Academy of Dermatology and Venereology, 2012
- Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarkerJournal of Neurosurgery, 2011
- Quantitative fluorescence imaging of protoporphyrin IX through determination of tissue optical properties in the spatial frequency domainJournal of Biomedical Optics, 2011
- Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and OptimizationChemical Reviews, 2010
- Fluorescence Diagnosis of Subclinical Actinic KeratosesNew England Journal of Medicine, 2008
- Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis2007
- Fluorescence Diagnosis and Photodynamic Therapy in DermatologyMedical Laser Application, 2003